UDG Healthcare Public Limited Co. Directorate Change (1289N)

TIDMUDG

RNS Number : 1289N

UDG Healthcare Public Limited Co.

28 January 2021

UDG Healthcare plc

("UDG" or "the Company")

28 January 2021

Directorate Changes

Following a review of the composition of the Board Committees, UDG is pleased to announce the following Committee changes, all of which are effective from 1 February 2021:

Nominations, Governance & Sustainability Committee

Linda Wilding will step down from the Nominations, Governance & Sustainability Committee and Peter Chambré and Anne Whitaker will be appointed to this Committee.

Risk, Investment & Financing Committee

Shane Cooke will step down as Chair of the Risk, Investment & Financing Committee and will be replaced as Chair by Linda Wilding. Lisa Ricciardi will also step down from this Committee, with Liz Shanahan and Anne Whitaker being appointed to the Committee.

Remuneration Committee

Linda Wilding will step down as Chair of the Remuneration Committee and Peter Chambré will assume the role of Chair. Lisa Ricciardi will also step down as a member of the Remuneration Committee and Erik Van Snippenberg and Anne Whitaker will be appointed to this Committee.

Details of the composition of each Committee are available on our website at https://www.udghealthcare.com/investors/corporate-governance/board-committees/ .

This announcement is made in accordance with Listing Rule 9.6.11(3).

For further information, please contact:

UDG Healthcare plc

Damien Moynagh

General Counsel & Company Secretary

[phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOABCGDBXUDDGBR

(END) Dow Jones Newswires

January 28, 2021 04:30 ET (09:30 GMT)